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ABSTRACT  
   Adherence of infected erythrocytes to vascular endothelium causes acute endothelial cell 
(EC) activation during Plasmodium falciparum infection. Consequently, proteins stored in 
Weibel Palade (WP) bodies within EC are secreted into the plasma. Osteoprotegerin (OPG) 
binds to VWF and consequently is stored within WP bodies. Given the critical role of EC 
activation in the pathogenesis of severe malaria, we investigated plasma OPG levels in 
children with Plasmodium falciparum malaria. At presentation, plasma OPG levels were 
significantly elevated in children with cerebral malaria (CM) compared to healthy controls 
(means 16.0 versus 0.8ng/ml; p<0.01). Importantly, OPG levels were also significantly 
higher in children with CM who had a fatal outcome, compared to children with CM who 
survived. Finally, in children with CM, plasma OPG levels correlated with other established 
prognostic indices (including plasma lactate levels and peripheral parasite density). To further 
investigate the relationship between severe malaria and OPG, we utilized a murine model of 
experimental CM in which C57BL/6J mice were infected with P. berghei ANKA. 
Interestingly, plasma OPG levels were increased 4.6 fold within 24 hours following P. 
berghei inoculation. This early marked elevation in OPG levels was observed before any 
objective clinical signs were apparent, and preceded the development of peripheral blood 
parasitaemia. As the mice became increasingly unwell, plasma OPG levels progressively 
increased. Collectively, these data suggest that OPG constitutes a novel biomarker with 
prognostic significance in patients with severe malaria. In addition, further studies are 
required to determine whether OPG plays a role in modulating malaria pathogenesis.   
 
 
 
Keywords  
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INTRODUCTION  
   Plasmodium falciparum malaria continues to be associated with significant morbidity and 
mortality (1, 2). In particular cerebral malaria (CM), a severe encephalopathy caused by P. 
falciparum infection, has a mortality of 10 – 20% and a high rate of neurological sequelae in 
survivors (3). Although the molecular mechanisms underlying the pathogenesis of CM 
remain poorly understood, previous studies have demonstrated a critical role for endothelial 
cell (EC) activation (4, 5). In particular, a number of specific EC surface receptors, including 
CD36, endothelial protein C receptor (EPCR), E-selectin and intercellular adhesion molecule-
1 (ICAM-1), have been shown to regulate the adhesion and sequestration of P. falciparum-
infected erythrocytes (IE) within the microvasculature (6). Quantitative expression of these 
different EC surface receptors on EC surfaces is modified by inflammatory cytokines, such as 
interleukin-1 and TNF (7). In addition to these IE surface receptors, EC also contain 
intracellular storage organelles known as Weibel-Palade (WP) bodies (8). These WP bodies 
are rod-shaped organelles that can be up to 5µm in length and are specific to EC. von 
Willebrand factor (VWF) synthesis within EC is a prerequisite for WP body formation (9, 
10). In normal plasma, VWF circulates as a series of heterogeneous multimers. In contrast, 
VWF stored within WP bodies is enriched in high molecular weight multimers (HMWM) 
that demonstrate enhanced binding affinities for both collagen and platelets (8, 10). In 
addition, a number of other EC proteins have also been identified as WP body constituents. 
These include VWF propeptide (VWFpp), P-selectin, factor VIII, angiopoietin-2, tissue-type 
plasminogen activator (tPA), interleukin-8, galectin-3 and osteoprotegerin (OPG) (8, 10). 
Following acute EC activation, WP bodies fuse with the EC surface membrane, and their 
contents are secreted directly into the plasma.  
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    Previous studies from our laboratory and others have demonstrated that plasma levels of 
HMWM VWF and VWFpp are both markedly elevated in patients with severe P. falciparum 
malaria (11-17). Furthermore, plasma VWF:Ag and VWFpp levels have also been shown to 
correlate with other biochemical prognostic markers in patients with severe malaria (14, 18). 
Interestingly, in a study of healthy volunteers infected with P. falciparum, de Mast et al 
observed that the increase in plasma VWF:Ag and VWFpp levels was evident from a very 
early stage following P. falciparum infection (19). The molecular mechanism(s) underlying 
this early marked EC activation and WP body secretion have not been defined. Nevertheless, 
emerging data suggest that the early release of WP body contents, and in particular VWF, 
may play a role in malaria pathogenesis. We recently reported that platelet-decorated 
HMWM VWF strings on the surface of activated EC can directly adhere to trophozoite-stage 
P. falciparum IE in a shear-based assay (20). Thus, the rapid release of HMWM VWF 
multimers from WP bodies, which occurs at an early stage in the clinical course of P. 
falciparum infection, may provide a novel mechanism through which IE can adhere to 
activated EC surfaces.  
   In keeping with the marked elevated VWF and VWFpp levels observed in children with 
cerebral malaria (CM), plasma levels of Angiopoietin-2 (Ang-2), another protein stored 
within WP bodies, are also significantly elevated (11, 13, 21, 22). Moreover, higher plasma 
Ang-2 levels have also been associated with a worse clinical outcome (21-23). 
Osteoprotegrin (OPG) is another EC protein stored within WP bodies (24). OPG is recruited 
into WP bodies by binding directly to the A1 domain of VWF (24, 25). OPG plays a key role 
in regulating bone remodelling by acting as a soluble decoy receptor for Receptor Activator 
of NFκB Ligand (RANKL) expressed on osteoblasts (26). Recent studies have also identified 
functional roles for OPG in modulating vascular biology (27, 28). In particular, OPG has 
been shown to upregulate expression of adhesion molecules on EC surfaces, and thereby 
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facilitate leucocyte adhesion (29, 30). Furthermore, OPG influences EC apoptosis, and 
elevated OPG levels have been associated with vascular disease (27, 28). Given the key role 
of EC activation in the pathogenesis of severe P. falciparum malaria, we have investigated 
plasma OPG levels in children with cerebral malaria. To further understand the relationship 
between WP body secretion and malaria, we have investigated OPG levels in an established 
murine model of experimental CM.  
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MATERIALS AND METHODS  
Patient samples 
   Children aged 6 months to 12 years were recruited at Queen Elizabeth Central Hospital, 
Blantyre, Malawi between 2008 and 2011. Children were recruited into one of 4 
prospectively defined groups: [1] CM, defined as Blantyre coma score ≤ 2, peripheral P. 
falciparum parasitaemia and an absence of clinical evidence for another cause of coma; [2] 
uncomplicated malaria, defined as an acute febrile illness in a child with peripheral P. 
falciparium parasitaemia and no evidence of organ compromise; [3] non-malarial febrile 
illness, defined acute febrile illness in a aparasitaemic child with no evidence of organ 
compromise and; [4] healthy controls, recruited from otherwise well children having elective 
surgery. We screened for parasitaemia using a rapid diagnostic test that employs a P. 
falicaprum specific antigen (First Response, Premier Medical, India) and if positive, 
peripheral parasite density was confirmed and quantified by thick and thin blood smears, as 
described previously (31). We have published data examining coagulation factors and soluble 
receptors in this cohort previously (31, 32) but the data presented here on VWF and OPG 
levels is presented for the first time. The study was approved by the ethical boards at the 
College of Medicine in Malawi (no. P.02/ 10/860) and Liverpool School of Tropical 
Medicine in the United Kingdom (no. 09.74). Informed consent was obtained from the 
parents or legal guardians of all the children enrolled in this study in accordance with the 
Declaration of Helsinki.  
 
Murine studies 
   Previous studies have demonstrated that wild type (WT) C57BL/6 mice infected with P. 
berghei ANKA develop a complex neurological syndrome that includes many similar clinical 
features (including paralysis, seizures and coma) to those observed in patients with CM (33-
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35). Depending upon the P. berghei inoculation dose, mice typically die within 6 to 10 days 
from this experimental CM. Consequently we used this murine model of experimental CM to 
further investigate the relationship between severe malaria and OPG. All mouse experiments 
were performed in compliance with Irish Medicines Board regulations, and were reviewed 
and approved by the Trinity College Dublin BioResources Ethical Committee. WT C57BL/6J 
mice were bred in-house under standard pathogen-free conditions, and all experiments were 
performed on mice aged 8 to 10 weeks. Mice were infected by intraperitoneal injection of 
2x106 P. berghei ANKA. Following inoculation, the mice were monitored using a previously 
validated clinical scoring system to assess progression of experimental CM (36). In addition, 
peripheral blood P. berghei parasitaemia levels were monitored daily by examination of 
Giemsa-stained thin blood smears obtained from tail vein bleeds. Blood samples at 
predefined time points following P. berghei infection were also collected by cardiac puncture 
into acid citrate dextrose (ACD) anticoagulant (85mM trisodium citrate, 65mM citric acid, 
100mM glucose) (Sigma, Ireland). Platelet-poor plasma was prepared by centrifugation of 
blood samples at 1500 g for 15 min at 20°C. The samples were then aliquoted and stored at -
80°C until use.  
 
Determination of plasma VWF:Ag and OPG levels 
   Human plasma VWF:Ag levels were measured using a previously described enzyme-linked 
immunosorbent assay (ELISA) (37). In brief, Maxisorp plates (Nunc, Denmark) were coated 
with rabbit anti-human VWF antibody (Dako, Denmark) in 50mM sodium carbonate buffer. 
After blocking with 3% bovine serum albumin (Sigma, Ireland) test samples or reference 
plasma were then added at appropriate dilutions. Bound VWF was subsequently detected 
using horseradish peroxidase–conjugated (HRP) rabbit anti-human VWF antibody (Dako, 
Denmark). Following further washing, HRP substrate 3,3’,5,5’-Tetramethylbenzidine (TMB; 
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Substrate Reagent Pack, R&D Systems, UK) was then added, and the reaction finally 
terminated by addition of 1M H2SO4. Absorbance was read at 450nM using a VERSAmax 
microplate reader (Molecular Devices, UK). Human and murine plasma OPG levels were 
determined using commercial OPG ELISAs (Osteoprotegerin/TNFRSF11B DuoSet®, R&D 
Systems, UK) performed in accordance with the manufacturer’s guidelines. 
 
Statistical analysis 
   All experimental data and statistical analysis were performed using the GraphPad Prism 
program (Graphpad Prism version 5.0 for Windows; GraphPad Software, Inc. San Diego, 
CA) and statistical significance was assigned at a value of P<0.05. Normally distributed data 
were expressed as mean values ± standard error of the mean (SEM). To assess statistical 
differences, data were analysed using Student’s unpaired 2-tailed t test. The Spearman 
correlation coefficient was used to determine linear association between different variables.   
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RESULTS  
 
Clinical characteristics 
   A total of 135 children with cerebral malaria, 45 children with non-malarial febrile illness, 
52 children with uncomplicated malaria and 26 healthy controls were enrolled in this study. 
Baseline clinical and laboratory characteristics are summarized in Table 1.  
 
Plasma VWF:Ag and OPG levels are markedly elevated in children with CM 
   At presentation, plasma VWF:Ag levels were significantly elevated in Malawian children 
with CM compared to healthy control children (means 29.7 versus 8.3µg/mL; p<0.001) 
(Figure 1A). This ~3.6 fold increase is similar in magnitude to that previously reported in 
other cohorts of paediatric and adult patients with severe P. falciparum infection (12, 14-16). 
Plasma VWF:Ag levels were also mildly increased in children with uncomplicated malaria 
(UM). However the elevation in plasma VWF:Ag observed in children with UM was similar 
to that observed in children with other non-malarial febrile illnesses (NMFI). Plasma OPG 
levels were also markedly elevated in children with CM compared to healthy controls (means 
16.0 versus 0.79ng/mL; p<0.01) (Figure 1B). However in contrast to the 3.6 fold increase 
observed in VWF:Ag levels, plasma OPG levels were increased more than 20 fold. 
Interestingly, in children with CM, plasma OPG levels varied over a wide range, which may 
reflect that individal children were presenting at different times in the progression of their 
malaria.Plasma OPG levels were also significantly elevated in children with UM compared to 
healthy controls (p<0.05). Although plasma VWF:Ag levels were significantly elevated in 
children with NMFI, plasma OPG levels were not significantly increased in this cohort. Thus, 
the marked increase in OPG seems to constitute a relatively malaria-sensitive phenomenon. 
Collectively, these findings support the hypothesis that acute endothelial cell activation and 
WP body secretion constitute characteristic features of severe P. falciparum malaria. In 
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addition, these data further demonstrate for the first time that plasma OPG levels are 
markedly elevated in children with P. falciparum. 
 
Plasma OPG levels relate to malarial severity in children with P. falciparum malaria 
   In patients with severe P. falciparum malaria, it is well established that plasma lactate 
levels constitute a useful biochemical prognostic indicator (38). Unsurprisingly, plasma 
lactate levels were significantly elevated in children with CM compared to healthy controls 
(means 6.9 versus 2.0mmol/L; p<0.001) (Figure 2A). In addition, plasma lactate levels were 
significantly higher in children with CM compared to those with UM respectively (p<0.001). 
Among the 135 children with confirmed CM, plasma OPG levels and lactate levels were 
significantly correlated (r=0.42, p<0.001) (Figure 2B). Eighty four children with CM 
demonstrated plasma lactate levels greater than 5mmol/L consistent with lactic acidosis. 
Plasma OPG levels in children with CM and lactic acidosis were higher compared to levels in 
children with CM uncomplicated by lactic acidosis (means 19.6 versus 10.2; p=0.06). 
Importantly, plasma OPG levels at admission were also significantly higher in the 21 children 
with CM who later died, than in the 114 children with CM who survived (means 29.6 versus 
14ng/mL; p=0.026) (Figure 3A). Peripheral parasite density and platelet count have 
previously been defined as markers of disease severity in patients with severe P. falciparum. 
In previous studies, we found no significant correlation between plasma VWFpp levels and 
peripheral parasite density (14, 15). In contrast, in children with CM we observed an 
association between OPG levels and parasite density (r=0.65; p<0.001) (Figure 3B). OPG 
levels were also negatively associated with platelet count (r= -0.5; p<0.001) (Figure 3C).  
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Plasma OPG levels are markedly elevated in experimental CM 
   To further investigate the relationship between severe malaria and OPG, we utilised an 
established murine model of experimental CM. In this model, C57BL/6J mice were infected 
with P. berghei ANKA. Malaria progression was then assessed using a previously validated 
clinical scoring algorithm (36). Using this algorithm, overt clinical signs of malaria were first 
observed on Day +3 following P. berghei infection. Subsequently, the infected mice became 
progressively unwell, with death typically occurring 6-7 days after infection (Figure 4A). 
Peripheral blood smear analysis demonstrated that P. berghei parasitaemia levels were first 
detectable 48 hours following inoculation (Figure 4B). Thereafter, blood parasitaemia levels 
progressively increased as the malaria infection progressed. In keeping with our findings in 
children with CM, a significant increase in plasma OPG levels was also observed in wild type 
C57BL/6J mice following P. berghei infection (Figure 4C). For example, by Day +5 
following inoculation, mean murine plasma OPG levels were increased approximately 18 
fold (1.38ng/ml at Day 0 versus 25.5ng/ml at Day+5; p<0.001). This increase in murine 
plasma OPG levels seen was thus strikingly similar in magnitude to that observed in children 
with P. falciparum CM.  
   Interestingly, a significant increase in plasma OPG levels was observed from a very early 
stage following P. berghei infection. Plasma OPG levels were already increased 4.6 fold 
(1.38 versus 6.4ng/ml; p<0.05) within 24 hours following P. berghei inoculation. This early 
marked elevation in murine plasma OPG levels was established before any objective clinical 
signs were apparent (Figure 4A). Furthermore, the increase in plasma OPG levels also 
preceded the development of significant peripheral blood parasitaemia levels (Figure 4B). As 
the mice became increasingly unwell, plasma OPG levels progressively increased. Finally, 
and again in keeping with our observations in children with CM, a correlation between 
plasma OPG levels and peripheral blood parasitaemia levels was also observed in the murine 
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ECM model (r=-0.9; p=0.08). Collectively, these findings confirm that marked elevation in 
plasma OPG constitutes a consistent finding in both human and experimental murine CM. 
Moreover, the increase in plasma OPG occurs at an early stage during the pathogenesis of 
severe malaria infection.  
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DISCUSSION  
   EC activation plays a critical role in modulating the pathogenesis underlying severe P. 
falciparum malaria (4, 5). This EC activation triggers the secretion of WP body contents into 
the plasma. Previous studies have consistently shown that plasma levels of WP body-stored 
HMWM VWF are significantly increased in patients with both P. falciparum and P. vivax 
malaria (12, 14-16). Furthermore, significant elevations in the plasma levels of other WP 
components (including VWFpp and Ang-2) have also been previously reported in patients 
with malaria infection (13, 14, 21). In this study, we demonstrate for the first time that severe 
P. falciparum malaria is also associated with a marked increase in plasma OPG levels. 
Although the biological mechanism(s) responsible for this increase in OPG have not been 
defined, it seems likely that fulminant acute endothelial cell activation is at least in part 
responsible. Interestingly, we observed a similar marked increase in plasma OPG levels in a 
murine model of experimental CM. In addition, using this murine model we demonstrated 
that the increase in plasma OPG develops at an early stage following malaria infection. 
Indeed, plasma OPG levels were significantly increased before parasitaemia was detectible, 
and well before the onset of any clinical signs. This finding is consistent with previous 
studies in which elevations in plasma VWF levels were observed at a surprisingly early stage 
in both human volunteers infected with P. falciparum, and in mice infected with P. berghei 
(19).  
    
   The early and marked increase in plasma OPG levels associated with malaria may represent 
an epiphenomenon, consistent with acute EC activation and WP body secretion. 
Alternatively, it is possible that OPG may have a role in the pathogenesis of severe malaria. 
Although OPG has an established role in regulating osteoclast differentiation, more recent 
studies have identified additional novel biological functions. Of particular relevance, OPG 
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has been shown to influence the expression of adhesion molecules on the EC surface, and to 
modulate EC apoptosis (28-30). For example, in vitro studies have shown that OPG increases 
expression of Ang-2, VCAM-1, and ICAM1 on HUVEC (29). Interestingly, in this study we 
found significant correlations between plasma OPG levels and several other prognostic 
markers (including plasma lactate levels, parasitaemia and thrombocytopenia) in children 
with CM. Further studies will be required to determine whether OPG plays any direct role in 
contributing to malaria pathogenesis.  
    
   Notwithstanding any putative role of OPG in malaria pathogenesis, our combined human 
and animal data support the hypothesis that plasma OPG levels may constitute a novel 
biomarker in malaria. However, the clinical utility of changes in plasma OPG levels as a 
measure of malaria severity, or indeed as a useful diagnostic or prognostic clinical tool, 
remains to be established. In this context, it is interesting that although both VWF and OPG 
are stored together within WP bodies, the increase in plasma OPG levels in children with CM 
was much more marked than that in VWF levels. This discrepancy may relate to different 
relative concentrations of VWF and OPG being stored within WP bodies. Alternatively, it is 
not known whether significant differences in plasma half-life may exist between OPG and 
VWF. Finally, significant OPG synthesis has also been described in other non-EC tissues 
(e.g. smooth muscle cells) (39). Consequently, although WP secretion is likely to be 
important in the aetiology of the markedly elevated plasma OPG levels in severe malaria, our 
findings do not preclude the possibility that the increased plasma OPG may also be in part 
derived from other cells. Additional studies to define the cellular origins of the markedly 
elevated plasma OPG levels will therefore be of interest. 
   The combined increases in plasma levels of both VWF and OPG observed in severe malaria 
are of further interest in that previous studies have demonstrated that OPG can bind directly 
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to the A1 domain of VWF (24, 25). This OPG-VWF binding occurs within EC prior to 
secretion from WP bodies (25). Due to the ionic conditions existing in normal plasma, it 
seems unlikely that any further OPG binding to VWF takes place in the peripheral 
circulation. Nevertheless, VWF-OPG complexes formed prior to secretion from WP bodies 
have been shown to remain relatively stable in normal plasma (25). Further studies will be 
required to determine whether increased levels of this VWF-OPG complex are circulating in 
patients with severe malaria. Moreover, it remains unclear whether the formation of this 
complex has any effect upon the normal functional properties of either VWF and/or OPG 
respectively. 
 
   In conclusion, we have shown that plasma OPG levels are elevated approximately 20 fold 
in both children with CM, and in a murine model of experimental CM. This marked increase 
in plasma OPG is evident from an early stage following malaria infection. Furthermore, 
plasma OPG levels increase progressively throughout the course of infection, and correlate 
with other established markers of outcome in patients with severe malaria. Collectively, these 
findings suggest that OPG may have a role as a novel biomarker in patients with severe 
malaria infection, and also raise the intriguing possibility that OPG may play a role in 
modulating malaria pathogenesis.   
 
 
 
 
 
 
  
O’Regan et al  Elevated plasma OPG in cerebral malaria 
   
	
16	
	
AUTHORSHIP 
Contribution: N. O’R., C. A. M., K. G., J. M. O’S., A. C., and T. M. B. performed 
experiments; N. O’R., C. A. M., K. G., J. M. O’S., T. M. B., R. J. S. P., O. P. S., A. G. C., and 
J. S. O’D. designed the research and analyzed the data. All authors were involved in writing 
and reviewing the paper. 
 
Conflict-of-interest disclosure:  
None applicable. 
 
ACKNOWLEDGEMENTS 
This work was supported by the Children’s Medical and Research Foundation, Our Lady’s 
Children’s Hospital, Crumlin (O.S., A.C. and J.S.O’D), a Clinical PhD Fellowship from The 
Wellcome Trust, UK (C. A. M.), grants from the NIH (T. E. T., 5R01AI034969-14) and 
through a Science Foundation Ireland Principal Investigator Award (11/PI/1066; J.S.O’D.). 
The Malawi–Liverpool Wellcome Trust Clinical Research Programme is supported by core 
funding from The Wellcome Trust (084679/Z/08/Z). 
For coordinating the cerebral malaria pathogenesis study in Blantyre we would like to thank 
Terrie Taylor and Karl Seydel (Michigan State University and Blantyre Malaria Project). For 
recruiting and caring for patients, we would like to thank the nurses and clinicians on the 
Paediatric Research Ward team (Malawi– Liverpool-Wellcome Trust Clinical Research 
Programme and Blantyre Malaria Project), and the nurses and clinicians in the Department of 
Paediatrics and Child Health (Queen Elizabeth Hospital, Blantyre, Malawi).  
 
 
 
  
O’Regan et al  Elevated plasma OPG in cerebral malaria 
   
	
17	
	
FIGURE LEGENDS 
Table 1: Patient characteristics and baseline data for children enrolled. 
(n.a. = not applicable; n.d. = not done). 
 
Figure 1:  Plasma VWF:Ag and OPG are markedly elevated in children with CM  
(A) Plasma VWF:Ag and (B) OPG levels were determined by ELISA in children presenting 
with cerebral malaria (CM), uncomplicated malaria (UM), or non-malarial febrile illness 
(NMFI) as well as in a cohort of healthy control children. Each plasma sample was tested in 
duplicate at three dilutions, and mean values for each group are shown. VWF:Ag and OPG 
levels were significantly elevated in children with CM compared to controls. An unpaired 
student’s t-test was performed for statistical analysis and significance is indicated as follows: 
* P<0.05, ** P<0.01, *** P<0.0001 respectively.  
 
Figure 2: Relationship between plasma OPG levels and lactate levels in children 
with CM  
(A) Plasma lactate levels were performed by ELISA in children with CM, UM, NMFI and 
healthy controls. (** P<0.01, *** P<0.0001, n.s. = not significant). 
(B) Relationship between plasma OPG levels and lactate levels in children with CM. The 
dashed red line at 5mmol/L defines plasma lactate level considered diagnostic of lactic 
acidosis. 
 
Figure 3: Plasma OPG levels relate to malaria severity in children with P. 
falciparum malaria  
(A) Plasma OPG levels at presentation in children with CM and a fatal outcome were 
compared to those of children with CM and a non-fatal outcome. 
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(B) Plasma OPG levels in children with CM correlated with peripheral blood P. falciparum 
levels (C) Plasma OPG levels inversely correlated with platelet count in children with CM. 
 
Figure 4: Marked elevation in plasma OPG levels constitutes an early and 
characteristic feature of experimental CM 
WT C57BL/6J mice (n=12) mice were inoculated with 2 x106 P. berghei ANKA parasites. 
(A) Clinical progression of the malaria infection was assessed were compared using a 
validated clinical scoring algorithm. Results presented illustrated represent the mean values ± 
SEM unless otherwise stated.  
(B) Following infection with P. berghei, peripheral blood parasitaemia levels were 
determined on a daily basis from Giemsa-stained smears.  
(C) Whole blood samples were collected from infected mice by cardiac puncture, and plasma 
OPG levels were then measured at pre-defined time points using ELISA. All ELISAs were 
performed in triplicate, and results presented represent the mean values ± SEM (* P<0.05, ** 
P<0.01, *** P<0.0001 respectively). 
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What is known about this topic? 
• Acute EC activation plays a critical role in the pathogenesis of P. falciparum malaria. 
This EC activation results in release of proteins stored within Weibel Palade bodies 
including VWF and Ang-2. 
• OPG binds to the A1 domain of VWF and consequently is also stored within the WP 
bodies of EC. 
 
What does this paper add? 
• Plasma OPG levels are markedly elevated in children with cerebral malaria. 
• Plasma OPG levels correlate with clinical severity, and inversely with clinical 
outcome, in chidren with severe P. falciparum malaria. 
• Plasma OPG levels are also markedly elevated from an early stage in a murine model 
of experimental CM. 
